-
The Indianapolis-based pharmaceutical company, Eli Lilly and Company, announced Wednesday it will lower the prices of its branded insulin by 70 percent and will introduce more price caps for its non-branded insulin.
-
T1International, an advocacy group for type 1 diabetics, is calling on pharmaceutical companies like Eli Lilly to lower their insulin prices. The group has been pushing these efforts in Indianapolis for several years.
-
A handful of state departments have to figure out ways to lower the cost of insulin in Michigan by mid-December. That’s under a directive issued by the governor Monday.
-
The price of insulin has more than tripled in the past two decades; A one-month supply of Eli Lilly’s Humalog has jumped from $21 in 1996 to about $275 in 2019.
-
The Genesee County Democrat introduced the Affordable Insulin Now Act in the U.S. House on Friday. It would cap the price tag for a month’s supply of insulin at $35, regardless of insurance.
-
The Michigan attorney general’s office has launched an investigation into what it calls excessive insulin prices, specifically targeting Eli Lilly, one of the largest drug companies in the U.S.
-
Indianapolis-based Eli Lilly is joining other pharmaceutical companies in arguing against legislation that aims to reduce drug costs. Congress is debating…
-
Diabetes advocates say Eli Lilly’s latest price reduction on one of its generic insulins is not enough. One group says the cost of insulin is still…
-
Indianapolis-based pharmaceutical company Eli Lilly is reducing the list price of one of its frequently-used insulins for a second time in the last two…
-
The Indiana State Department of Health reported 30 additional deaths Wednesday, bringing the state’s total to 203. The state announced nearly 6,000 total…